Generex Biotechnology Corporation

GNBT · OTC
Analyze with AI
7/31/2020
7/31/2019
7/31/2018
7/31/2017
Assets
Cash & Equivalents$15$298$1,046$2,879
Short-Term Investments$0$0$0$0
Receivables$165$36$34$0
Inventory$742$363$12$10
Other Curr. Assets$332$276$96$22
Total Curr. Assets$1,255$974$1,188$2,911
Property Plant & Equip (Net)$252$507$32$1
Goodwill$34,489$38,298$0$0
Intangibles$9,366$9,834$3,211$2,937
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$21$31$2,176$4,246
Total NC Assets$44,128$48,669$5,419$7,183
Other Assets$0-$16,981$0$0
Total Assets$45,383$32,662$6,607$10,095
Liabilities
Payables$23,908$19,056$11,045$10,173
Short-Term Debt$10,735$8,388$14,184$13,738
Tax Payable$0$0$0$0
Deferred Revenue$0$0-$24,909-$23,911
Other Curr. Liab.$6,729$1,502$24,909$23,911
Total Curr. Liab.$41,371$28,946$25,229$23,911
LT Debt$500$0$0$0
Deferred Rev, NC-$1,502$0$0$0
Deferred Tax Liab, NC$1,502$1,502,122$0$0
Other NC Liab.$15,470-$1,489,105$24,963$66,060
Total NC Liab.$15,970$13,017$24,963$66,060
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$57,341$41,963$50,192$89,971
Equity
Pref Stock$0$0$0$0
Common Stock$82$62$1$1
Retained Earnings-$452,063-$418,728-$409,386-$445,721
AOCI$780$797$798$783
Other Equity$429,744$408,567$370,579$370,579
Total Equity-$21,456-$9,302-$38,008-$74,358
Supplemental Information
Minority Interest$4,074$0-$5,576-$5,518
Total Liab. & Tot. Equity$35,885$32,662$6,607$10,095
Net Debt$11,219$8,090$13,138$10,859
Generex Biotechnology Corporation (GNBT) Financial Statements & Key Stats | AlphaPilot